← Home / CareDx, Inc. (CDNA)
Stock Analysis

CareDx, Inc. (CDNA)

CDNA
CDNA · Healthcare • Diagnostics & Research
49.85 +0.50%
Track CDNA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CDNA price is:
52W Range Position
94%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-09-04 00:15 UTC
WOI Investment Thesis
Constructive
Current market structure would strengthen above 53.66. Holding above 44.85 preserves the current price structure.
⚖️
Fundamentals
Strong / Strong / Healthy / Strong
Price Structure
Constructive
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
44.85
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
53.66
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
30
Financial Results
HIGH
CDNA reports financial results
(the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026.
8-K Filing SEC EDGAR
JUL
7
M&A
HIGH
CDNA merger or acquisition update
Completion of Acquisition or Disposition of Assets.
8-K Filing SEC EDGAR
JUN
15
Management / Board
MEDIUM
CDNA board and management update
(the “ Company ”) held its 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”).
8-K Filing SEC EDGAR
What's Driving CDNA?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
✓ Business quality is supportive
Revenue growth is strong. Profitability is strong. Cash generation is healthy. Balance-sheet quality is strong.
⚠️ Key risk remains
losing 44.85 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
No qualified technical setup is currently active.
RSI(14)
63.0
How to read this setup
The nearest decision zone is framed by support around 44.85 and resistance near 53.66. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
CDNA — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-09-03
Fair
Fair valuation
Valuation looks broadly balanced for a mature quality business.
Market Cap
$2.6B
Company size
EV
$2.2B
Debt-adjusted value
P/E
23.8
Reasonable
P/S
5.6
Balanced
P/B
6.0
Balanced
EV/Sales
4.8
Balanced
P/FCF
22.9
Reasonable
FCF Yield
4.37%
Cash return
Not financial advice
Business Lens
Strong financial quality
Growth, profitability, cash flow and balance sheet quality remain broadly supportive.
Revenue Growth
Strong
Profitability
Strong
Cash Flow
Healthy
Balance Sheet
Strong
💵 Revenue
131.95M
↗ Strong
📈 Net Income
110.64M
↗ Strong
🧮 EPS (Basic)
2.15
↗ Strong
CareDx, Inc.
Healthcare • Diagnostics & Research